187 related articles for article (PubMed ID: 37485373)
1. Correlation between gut microbiota and the development of Graves' disease: A prospective study.
Deng Y; Wang J; Xie G; Zou G; Li S; Zhang J; Cai W; Xu J
iScience; 2023 Jul; 26(7):107188. PubMed ID: 37485373
[TBL] [Abstract][Full Text] [Related]
2. Alterations of Gut Microbiota in Patients With Graves' Disease.
Chang SC; Lin SF; Chen ST; Chang PY; Yeh YM; Lo FS; Lu JJ
Front Cell Infect Microbiol; 2021; 11():663131. PubMed ID: 34026662
[TBL] [Abstract][Full Text] [Related]
3. Comparative assessment of gut microbial composition and function in patients with Graves' disease and Graves' orbitopathy.
Shi TT; Xin Z; Hua L; Wang H; Zhao RX; Yang YL; Xie RR; Liu HY; Yang JK
J Endocrinol Invest; 2021 Feb; 44(2):297-310. PubMed ID: 32449092
[TBL] [Abstract][Full Text] [Related]
4. The role and molecular mechanism of gut microbiota in Graves' orbitopathy.
Li Y; Luo B; Tong B; Xie Z; Cao J; Bai X; Peng Y; Wu Y; Wang W; Qi X
J Endocrinol Invest; 2023 Feb; 46(2):305-317. PubMed ID: 35986869
[TBL] [Abstract][Full Text] [Related]
5. Associations between gut microbiota and thyroidal function status in Chinese patients with Graves' disease.
Chen J; Wang W; Guo Z; Huang S; Lei H; Zang P; Lu B; Shao J; Gu P
J Endocrinol Invest; 2021 Sep; 44(9):1913-1926. PubMed ID: 33481211
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota May Play a Significant Role in the Pathogenesis of Graves' Disease.
Jiang W; Yu X; Kosik RO; Song Y; Qiao T; Tong J; Liu S; Fan S; Luo Q; Chai L; Lv Z; Li D
Thyroid; 2021 May; 31(5):810-820. PubMed ID: 33234057
[No Abstract] [Full Text] [Related]
7. Alteration in gut microbiota is associated with immune imbalance in Graves' disease.
Liu Y; Tang S; Feng Y; Xue B; Cheng C; Su Y; Wei W; Zhang L; Huang Z; Shi X; Fang Y; Yang J; Zhang Y; Deng X; Wang L; Ren H; Wang C; Yuan H
Front Cell Infect Microbiol; 2024; 14():1349397. PubMed ID: 38533382
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota in experimental murine model of Graves' orbitopathy established in different environments may modulate clinical presentation of disease.
Masetti G; Moshkelgosha S; Köhling HL; Covelli D; Banga JP; Berchner-Pfannschmidt U; Horstmann M; Diaz-Cano S; Goertz GE; Plummer S; Eckstein A; Ludgate M; Biscarini F; Marchesi JR;
Microbiome; 2018 May; 6(1):97. PubMed ID: 29801507
[TBL] [Abstract][Full Text] [Related]
9. Molecular Alteration Analysis of Human Gut Microbial Composition in Graves' disease Patients.
Ishaq HM; Mohammad IS; Shahzad M; Ma C; Raza MA; Wu X; Guo H; Shi P; Xu J
Int J Biol Sci; 2018; 14(11):1558-1570. PubMed ID: 30263008
[TBL] [Abstract][Full Text] [Related]
10. The Role of the Microbiota in Graves' Disease and Graves' Orbitopathy.
Hou J; Tang Y; Chen Y; Chen D
Front Cell Infect Microbiol; 2021; 11():739707. PubMed ID: 35004341
[TBL] [Abstract][Full Text] [Related]
11. Gut Dysbiosis Contributes to the Imbalance of Treg and Th17 Cells in Graves' Disease Patients by Propionic Acid.
Su X; Yin X; Liu Y; Yan X; Zhang S; Wang X; Lin Z; Zhou X; Gao J; Wang Z; Zhang Q
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785703
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiome and the Role of Metabolites in the Study of Graves' Disease.
Liu H; Liu H; Liu C; Shang M; Wei T; Yin P
Front Mol Biosci; 2022; 9():841223. PubMed ID: 35252357
[TBL] [Abstract][Full Text] [Related]
13. Alterations and Mechanism of Gut Microbiota in Graves' Disease and Hashimoto's Thyroiditis.
Zhao H; Yuan L; Zhu D; Sun B; Du J; Wang J
Pol J Microbiol; 2022 Jun; 71(2):173-189. PubMed ID: 35675824
[TBL] [Abstract][Full Text] [Related]
14. Characterizing the gut microbiota in patients with chronic kidney disease.
Hu X; Ouyang S; Xie Y; Gong Z; Du J
Postgrad Med; 2020 Aug; 132(6):495-505. PubMed ID: 32241215
[No Abstract] [Full Text] [Related]
15. Integrated microbiome and metabolome analysis reveals a distinct microbial and metabolic signature in Graves' disease and hypothyroidism.
Jiang W; Lu G; Qiao T; Yu X; Luo Q; Tong J; Fan S; Chai L; Gao D; Wang R; Deng C; Lv Z; Li D
Heliyon; 2023 Nov; 9(11):e21463. PubMed ID: 38034621
[TBL] [Abstract][Full Text] [Related]
16. Intestinal microbiota changes in Graves' disease: a prospective clinical study.
Yan HX; An WC; Chen F; An B; Pan Y; Jin J; Xia XP; Cui ZJ; Jiang L; Zhou SJ; Jin HX; Ou XH; Huang W; Hong TP; Lyu ZH
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32820337
[TBL] [Abstract][Full Text] [Related]
17. Preliminary Observation of the Changes in the Intestinal Flora of Patients With Graves' Disease Before and After Methimazole Treatment.
Yang M; Zheng X; Wu Y; Zhang R; Yang Q; Yu Z; Liu J; Zha B; Gong Q; Yang B; Sun B; Zeng M
Front Cell Infect Microbiol; 2022; 12():794711. PubMed ID: 35402292
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study.
Shi TT; Xin Z; Hua L; Zhao RX; Yang YL; Wang H; Zhang S; Liu W; Xie RR
J Endocrinol Invest; 2019 Aug; 42(8):967-978. PubMed ID: 30674011
[TBL] [Abstract][Full Text] [Related]
19. Alteration of the intestinal flora may participate in the development of Graves' disease: a study conducted among the Han population in southwest China.
Yang M; Sun B; Li J; Yang B; Xu J; Zhou X; Yu J; Zhang X; Zhang Q; Zhou S; Sun X
Endocr Connect; 2019 Jul; 8(7):822-828. PubMed ID: 31137015
[TBL] [Abstract][Full Text] [Related]
20. Elevated Levels of Circulating Biomarkers Related to Leaky Gut Syndrome and Bacterial Translocation Are Associated With Graves' Disease.
Zheng D; Liao H; Chen S; Liu X; Mao C; Zhang C; Meng M; Wang Z; Wang Y; Jiang Q; Xue Y; Zhou L; Chen Y
Front Endocrinol (Lausanne); 2021; 12():796212. PubMed ID: 34975767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]